Aktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78

Aktis Oncology, Inc.

Aktis Oncology, Inc.

AKTS

0.00
  • Aktis Oncology director Ken Herrmann sold 4,856 shares on July 20, 2026 at USD 24.56 per share.
  • He acquired the same 4,856 shares via option exercises priced at USD 0.08 and USD 1.91.
  • His directly held common stock position fell to zero following the transactions.
  • He reported 18,364 stock options remaining outstanding after the exercises.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aktis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-310991), on July 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.